|Salary:||£32,236 to £39,609 Grade 7 p.a.|
|Placed On:||20th June 2019|
|Closes:||18th July 2019|
We are currently recruiting for a Postdoctoral Scientist in Immunology reporting to Professor John Frater. The postholder will be a member of a research group with responsibility for carrying out research as part of the RIO Clinical Trial to determine the efficacy of broadly neutralising antibodies as new long-acting therapies for HIV infection. The RIO trial is a collaboration between Rockefeller University (New York), Imperial College (London) and Oxford University.
The postholder will be responsible for leading the cellular immunology components of the study, primarily to quantify and characterise the CD4 and CD8 T cell responses, but also to explore other components of the cellular response, including NK and innate-like responses.
This is an exciting opportunity at the cutting edge of new HIV therapeutics, and we are looking for an ambitious postdoctoral researcher or clinical fellow to lead this component of the research.
To be considered for this position you should have a DPhil/PhD or equivalent in the field of T cell immunology. You should have a track record of expertise in designing and carrying out assays including but not limited to Intracellular Cytokine Staining (ICS), ELISpot, Tetramer analyses. It is also expected that you should have experience of working with HIV and with multi-parameter flow cytometry.
The post is fixed-term for up to 3 years in the first instance.
Applications for this vacancy should be made online and you will be required to upload a supporting statement and CV as part of your application. The supporting statement must explain how you meet each of the selection criteria for the post using examples of your skills and experience.
The closing date for applications is 12.00 noon on Thursday 18 July 2019.
Type / Role: